Cite
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways
MLA
Vittoria Cammisotto, et al. “Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating Ox-LDL Pathways.” International Journal of Molecular Sciences, vol. 22, no. 13, July 2021, p. 7193. EBSCOhost, https://doi.org/10.3390/ijms22137193.
APA
Vittoria Cammisotto, Francesco Baratta, Valentina Castellani, Simona Bartimoccia, Cristina Nocella, Laura D’Erasmo, Nicholas Cocomello, Cristina Barale, Roberto Scicali, Antonino Di Pino, Salvatore Piro, Maria Del Ben, Marcello Arca, Isabella Russo, Francesco Purrello, Roberto Carnevale, Francesco Violi, Daniele Pastori, & Pasquale Pignatelli. (2021). Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL Pathways. International Journal of Molecular Sciences, 22(13), 7193. https://doi.org/10.3390/ijms22137193
Chicago
Vittoria Cammisotto, Francesco Baratta, Valentina Castellani, Simona Bartimoccia, Cristina Nocella, Laura D’Erasmo, Nicholas Cocomello, et al. 2021. “Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating Ox-LDL Pathways.” International Journal of Molecular Sciences 22 (13): 7193. doi:10.3390/ijms22137193.